Autism Research Institute

Research

The Autism Research Institute (ARI) is proud to be the only autism non-profit to be awarded the coveted 'Four Star Award" by Charity Navigator for sound fiscal management. ARI is even prouder of its unique track record in funding research projects which have made a real difference in discovering the true causes of autism, and developing effective treatments that bring about recovery from autism.

ARI-funded research has dispelled the conventional belief that autism is always an untreatable lifelong disability. ARI funds research intended to bring results, and not to demonstrate "political correctness." ARI funds research on controversial topics, including the role of environmental toxins and thimerosal in vaccines causing the autism epidemic -- topics ignored and avoided by the larger, mainstream organizations. Thousands of parents and physicians worldwide credit ARI with bringing recovery or near-recovery to autistic patients.

Advances in Autism Research - April 2008

ARI-funded Research (2007)
A Sampling of Past ARI-Funded Grants
Scientific Foundations of a Defeat Autism Now! Protocol

Donate to Support ARI Research

Research Papers

  • Metals, both essential and toxic, are found in the human body and more than one quarter of the elemts known in the periodic table are essential for human life
  • Heavy Metal Exposures, Developmental Milestones, and Physical Symptoms in Children with Autism
  • Binding of Infectious Agents, Toxic Chemicals, and Dietary Peptides to Tissue Enzymes and Lymphocyte Receptors and Consequent Immune Response in Autism
  • Impaired transsulfuration and oxidative stress in autistic children: Improvement with targeted nutritional intervention
  • Effects of Mercury on Methionine Synthase: Implications for Disordered Methylation in Autism
  • B6 and Sulfation
  • The Cerebellum and Autism
  • Studies of High Dosage Vitamin B6 (and often with Magnesium) in Autistic Children and Adults

    Science Session Presentations

    • New Evidence for DNA Hypomethylation and Increased Vulnerability to Oxidative Stress in Autism
      Jill James, PhD (Seattle 2006)
    • Response to Peroxisome Proliferator-Activated Receptors (PPARs) in the Autistic population
      Marvin Boris, MD (Seattle 2006)
    • Methionine Synthase: A Redox Sensor and First Responder to Oxidative Stress
      Richard Deth, PhD (Seattle 2006)
    • Autism is Treatable: Scientific Plausibility
      Martha Herbert, MD, PhD (Seattle 2006)
    • Methylation Panel: Autism and Methyl B12
      James Neubrander, MD (DC 2006)
    • Methylation Panel: Transmethylation Overview
      Derrick Lonsdale, MD (DC 2006)
    • Methylation Panel: Methionine Synthase: A Redox Sentinel at the Intersection of Life
      Richard Deth, PhD (DC 2006)
    • Methylation Panel: New Evidence and Implications of DNA Hypomethylation in Autistic Children
      S. Jill James, PhD (DC 2006)
    • Recent Findings on the Nutritional Abnormalities in Autism
      Jim  Adams, PhD (DC 2006)
    • Follow the Science: Synergy and Synchrony in Autism
      Elizabeth Mumper, MD (Long Beach 2005)
    • Autism: Evidence it can be treated
      Jeff Bradstreet, MD, FAAFP (Milwaukee 2006)
    • Recovery: Going Home with a Plan for Using the Best that Defeat Autism Now! Offers
      Jeff Bradstreet, MD (Seattle 2006)

    • © 2007-2008 Autism Research Institute | Sitemap | Notices | Webcasts